Assessment of LAMPAuris for Rapid Detection of Candida Auris in Clinical Specimens

Overview

Journal Mycopathologia

Specialties Microbiology
Pharmacology

Date 2024 Sep 23

PMID 39312077

Authors

Mikachi Yamamoto

Mohamed Mahdi Alshahni

Aya Komori

Masakazu Mimaki

Koichi Makimura

Affiliations

Soon will be listed here.

Abstract

Candida auris is a pathogenic yeast frequently exhibiting multidrug resistance and thus warrants special attention. The prompt detection and proper identification of this organism are needed to prevent its spread in healthcare facilities. The authors of this paper had previously developed LAMPAuris, a loop-mediated isothermal amplification assay, for the specific detection of C. auris. LAMPAuris is evaluated in this report for its ability to identify C. auris from five clades and to detect it from clinical specimens. A total of 103 skin swab samples were tested in comparison with a culture-based method and C. auris-specific SYBR green qPCR. The results show that the LAMPAuris assay had specificities ranging from 97 to 100% and sensitivities ranging from 66 to 86%. The lower sensitivity could be attributed to DNA degradation caused by the prolonged storage of the samples. In conclusion, LAMPAuris proved to be a rapid and reliable method for identifying C. auris and for detecting it in clinical specimens. Fresh specimens should ensure better yield and higher sensitivities.

Citing Articles

Current Updates on Molecular Diagnostic Assays Used for Detection of : A Systematic Review.

Wong R, Lee A, Cheung I, Chow V, Ip M, Lai C Diagnostics (Basel). 2025; 15(2).

PMID: 39857024 PMC: 11763552. DOI: 10.3390/diagnostics15020140.

References

Burki T . WHO publish fungal priority pathogens list. Lancet Microbe. 2023; 4(2):e74. DOI: 10.1016/S2666-5247(23)00003-4. View

Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H . Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009; 53(1):41-4. DOI: 10.1111/j.1348-0421.2008.00083.x. View

Rhodes J, Fisher M . Global epidemiology of emerging Candida auris. Curr Opin Microbiol. 2019; 52:84-89. DOI: 10.1016/j.mib.2019.05.008. View

Lockhart S, Etienne K, Vallabhaneni S, Farooqi J, Chowdhary A, Govender N . Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2016; 64(2):134-140. PMC: 5215215. DOI: 10.1093/cid/ciw691. View

Chow N, de Groot T, Badali H, Abastabar M, Chiller T, Meis J . Potential Fifth Clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019; 25(9):1780-1781. PMC: 6711235. DOI: 10.3201/eid2509.190686. View

Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J . Confirmation of fifth clade by whole genome sequencing. Emerg Microbes Infect. 2022; 11(1):2405-2411. PMC: 9586689. DOI: 10.1080/22221751.2022.2125349. View

Tharp B, Zheng R, Bryak G, Litvintseva A, Hayden M, Chowdhary A . Role of Microbiota in the Skin Colonization of Candida auris. mSphere. 2023; 8(1):e0062322. PMC: 9942586. DOI: 10.1128/msphere.00623-22. View

Lee E, Choi M, Lee K, Kim D, Jeong S, Song Y . Intrahospital transmission and infection control of Candida auris originating from a severely infected COVID-19 patient transferred abroad. J Hosp Infect. 2023; 143:140-149. DOI: 10.1016/j.jhin.2023.10.017. View

Tamura T, Alshahni M, Makimura K . Evaluation of CHROMagar™ Candida Plus chromogenic agar for the presumptive identification of Candida auris. Microbiol Immunol. 2022; 66(6):292-298. DOI: 10.1111/1348-0421.12973. View

10.

Sasoni N, Maidana M, Latorre-Rapela M, Morales-Lopez S, Berrio I, Gamarra S . Candida auris and some Candida parapsilosis strains exhibit similar characteristics on CHROMagarTMCandida Plus. Med Mycol. 2022; . DOI: 10.1093/mmy/myac062. View

11.

de Jong A, Al-Obaid K, Mohd Tap R, Gerrits van den Ende B, Groenewald M, Joseph L . Candida khanbhai sp. nov., a new clinically relevant yeast within the Candida haemulonii species complex. Med Mycol. 2023; 61(2). PMC: 9936790. DOI: 10.1093/mmy/myad009. View

12.

Lee W, Shin J, Uh Y, Kang M, Kim S, Park K . First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011; 49(9):3139-42. PMC: 3165631. DOI: 10.1128/JCM.00319-11. View

13.

Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y . Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013; 31(1):90-1. DOI: 10.4103/0255-0857.108746. View

14.

Calvo B, Melo A, Perozo-Mena A, Hernandez M, Francisco E, Hagen F . First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016; 73(4):369-74. DOI: 10.1016/j.jinf.2016.07.008. View

15.

Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R . Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2013; 33(6):919-26. DOI: 10.1007/s10096-013-2027-1. View

16.

Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R . Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?. J Clin Microbiol. 2016; 55(2):638-640. PMC: 5277535. DOI: 10.1128/JCM.02202-16. View

17.

Ambaraghassi G, Dufresne P, Dufresne S, Vallieres E, Munoz J, Cuomo C . Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study. J Clin Microbiol. 2019; 57(11). PMC: 6812989. DOI: 10.1128/JCM.00884-19. View

18.

Ohshima T, Osaki T, Yamamoto Y, Asai S, Miyachi H, Kamiya S . Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay. J Clin Microbiol. 2018; 56(12). PMC: 6258861. DOI: 10.1128/JCM.00555-18. View

19.

Gotoh K, Nishimura N, Takeuchi S, Hattori F, Horiba K, Isaji M . Assessment of the loop-mediated isothermal amplification assay for rapid diagnosis of Mycoplasma pneumoniae in pediatric community-acquired pneumonia. Jpn J Infect Dis. 2013; 66(6):539-42. DOI: 10.7883/yoken.66.539. View

20.

Kamachi K, Moriuchi T, Hiramatsu Y, Otsuka N, Shibayama K . Evaluation of a commercial loop-mediated isothermal amplification assay for diagnosis of Bordetella pertussis infection. J Microbiol Methods. 2016; 133:20-22. DOI: 10.1016/j.mimet.2016.12.009. View